文献速递糖尿病肥胖与代谢综合征

白人与黑人混合队列中白细胞介素-6、糖尿病与代谢综合征:卒中地理与种族差异原因研究

Interleukin-6, Diabetes, and Metabolic Syndrome in a Biracial Cohort: The Reasons for Geographic and Racial Differences in Stroke Cohort.
PubMed 文献 · Diabetes Care · 2024-01-01

在REGARDS队列中测量3399名糖尿病风险者和1871名代谢综合征风险者的基线血浆IL-6,随访约9.5年后发现糖尿病发生率为14%、代谢综合征为20%,且均随IL-6四分位升高而上升。IL-6、种族与中心性肥胖对糖尿病存在三阶交互作用(P=8×10⁻⁵),IL-6与糖尿病风险的关联仅在无中心性肥胖的白人参与者中具有统计学显著性。

要点

  • 糖尿病发生率14%,代谢综合征20%,均随IL-6四分位升高而上升。
  • IL-6、种族与中心性肥胖对糖尿病存在三阶交互作用(P=8×10⁻⁵)。
  • IL-6与糖尿病风险的关联仅在无中心性肥胖的白人参与者中具有统计学显著性。

核心结论

  • IL-6在黑人参与者和中心性肥胖者中较高,但IL-6与糖尿病风险的关联仅在无中心性肥胖的白人参与者中具有统计学显著性。
  • IL-6与代谢综合征风险的关联同样在低风险组更强。
  • 结果支持降低炎症以预防糖尿病的概念,但为减少种族差异需要更好的生物标志物。

研究设计与样本

  • REGARDS研究纳入30239名年龄≥45岁的黑人和白人成年人,于2003-2007年入组,随访约9.5年。
  • 基线血浆IL-6在3399名有 incident diabetes 风险的参与者和1871名有代谢综合征风险的参与者中测量。
  • 采用改良Poisson回归估计IL-6的相对危险度(RR)。

主要发现

  • 糖尿病发生率为14%,代谢综合征发生率为20%,两者发生率均随IL-6四分位升高而上升。
  • IL-6、种族与中心性肥胖对糖尿病存在三阶交互作用(P=8×10⁻⁵)。
  • 在黑人参与者中,有中心性肥胖者第四与第一IL-6四分位比较的RR为2.02(95%CI 1.00-4.07),无中心性肥胖者为1.66(95%CI 1.00-2.75)。
  • 在白人参与者中,有中心性肥胖者第四与第一IL-6四分位比较的RR为1.73(95%CI 0.92-3.26),无中心性肥胖者为2.34(95%CI 1.17-4.66)。
  • IL-6与代谢综合征的关联模式与糖尿病相似。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Black Americans have a greater risk of type 2 diabetes than White Americans. The proinflammatory cytokine interleukin-6 (IL-6) is implicated in diabetes pathogenesis, and IL-6 levels are higher in Black individuals. This study investigated associations of IL-6 with incident diabetes and metabolic syndrome in a biracial cohort. RESEARCH DESIGN AND METHODS: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study enrolled 30,239 Black and White adults age ≥45 years in 2003-2007, with a follow-up ∼9.5 years later. Baseline plasma IL-6 was measured in 3,399 participants at risk of incident diabetes and 1,871 at risk of metabolic syndrome. Relative risk (RR) by IL-6 was estimated with modified Poisson regression for both groups. RESULTS: Incident diabetes occurred in 14% and metabolic syndrome in 20%; both rates rose across IL-6 quartiles. There was a three-way interaction of IL-6, race, and central adiposity for incident diabetes (P = 8 × 10-5). In Black participants with and without central adiposity, RRs were 2.02 (95% CI 1.00-4.07) and 1.66 (1.00-2.75) for the fourth compared with first IL-6 quartile, respectively. The corresponding RRs were 1.73 (0.92-3.26) and 2.34 (1.17-4.66) in White participants. The pattern was similar for IL-6 and metabolic syndrome. CONCLUSIONS: Although IL-6 was higher in Black than in White participants and those with central adiposity, the association of IL-6 with diabetes risk was statistically significant only among White participants without central adiposity. The association with metabolic syndrome risk was similarly stronger in low-risk groups. The results support the concept of interventions to lower inflammation in diabetes prevention, but to reduce race disparities, better biomarkers are needed.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Palermo BJ, Wilkinson KS, Plante TB, et al. Interleukin-6, Diabetes, and Metabolic Syndrome in a Biracial Cohort: The Reasons for Geographic and Racial Differences in Stroke Cohort. Diabetes Care. 2024. PMID: 38237104. doi:10.2337/dc23-0914

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。